Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -6.00 is 13% below its 5-year average of -5.31, around the middle of its 5-year range (-11.80–-0.72).
20.79% above its 12-month average of -7.57.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.09.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 12 comparable quarters.
EARNINGS PER SHARE (EPS)
-6.00
EARNINGS PER SHARE (EPS) AVG TTM
-7.57
EARNINGS PER SHARE (EPS) AVG 3Y
-7.54
EARNINGS PER SHARE (EPS) AVG 5Y
-5.31
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+20.79%
CURRENT VS 3Y AVG
+20.40%
CURRENT VS 5Y AVG
-13.05%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
FibroBiologics, Inc. Common Stock
Market Cap
$2.47M
Earnings Per Share (EPS)
-6.00
TTM Avg
-7.57
3Y Avg
-7.54
5Y Avg
-5.31
Market Cap
$2.38M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.19
3Y Avg
-0.10
5Y Avg
-0.07
Market Cap
$2.37M
Earnings Per Share (EPS)
-2.00
TTM Avg
-3.12
3Y Avg
-4.82
5Y Avg
-95.40
Market Cap
$2.36M
Earnings Per Share (EPS)
-13.89
TTM Avg
-71.45
3Y Avg
-134.10
5Y Avg
-124.65
Market Cap
$2.59M
Earnings Per Share (EPS)
-120.15
TTM Avg
-233.70
3Y Avg
-422.85
5Y Avg
-533.30
Market Cap
$2.64M
Earnings Per Share (EPS)
-50.28
TTM Avg
-397.20
3Y Avg
-675.82
5Y Avg
-681.84
Market Cap
$2.05M
Earnings Per Share (EPS)
-5482.20
TTM Avg
-40335.15
3Y Avg
-7495867.58
5Y Avg
-46112025.05
Market Cap
$1.92M
Earnings Per Share (EPS)
-46.49
TTM Avg
-92.15
3Y Avg
-143.14
5Y Avg
-171.91
Market Cap
$3.09M
Earnings Per Share (EPS)
-22.20
TTM Avg
-27.40
3Y Avg
-44.30
5Y Avg
-249.07
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| FibroBiologics, Inc. Common Stock (FBLG) | $2.47M | -6.00 | -7.57 | -7.54 | -5.31 |
| iTonic Holdings Ltd. (ITOC)vs › | $2.38M | N/A | -0.19 | -0.10 | -0.07 |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.37M | -2.00 | -3.12 | -4.82 | -95.40 |
| GeoVax Labs, Inc. (GOVX)vs › | $2.36M | -13.89 | -71.45 | -134.10 | -124.65 |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.59M | -120.15 | -233.70 | -422.85 | -533.30 |
| iSpecimen Inc. (ISPC)vs › | $2.64M | -50.28 | -397.20 | -675.82 | -681.84 |
| Jaguar Health, Inc. (JAGX)vs › | $2.05M | -5482.20 | -40335.15 | -7495867.58 | -46112025.05 |
| Autonomix Medical, Inc. (AMIX)vs › | $1.92M | -46.49 | -92.15 | -143.14 | -171.91 |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.09M | -22.20 | -27.40 | -44.30 | -249.07 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.13M | -1.43 | -2.52 | -2.09 | -1.32 |
Trailing EPS (TTM)
$-6.00
Forward EPS (Est.)
$-3.00
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -8.35 |
| 2024-12-31 | -6.80 |
| 2023-12-31 | -11.80 |
| 2022-12-31 | -3.20 |
| 2021-12-31 | -0.97 |
| 2020-12-31 | -0.72 |
